Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes business.

Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...

Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.

Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that ...

Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion July 02, 2025 — 10:01 am EDT Written by Zacks Equity Research for Zacks -> ...

ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.